Phenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy.

Yang, S C

Phenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy. [electronic resource] - Journal of immunotherapy : official journal of the Society for Biological Therapy Oct 1991 - 326-35 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1053-8550

10.1097/00002371-199110000-00004 doi


Animals
Antibodies, Monoclonal--therapeutic use
Antigens, CD--immunology
Cytotoxicity Tests, Immunologic
Immunophenotyping
Immunotherapy--methods
Interleukin-2--therapeutic use
Lung Neoplasms--immunology
Lymphocytes, Tumor-Infiltrating--immunology
Melanoma--immunology
Mice
Recombinant Proteins--therapeutic use
Remission Induction--methods
Spleen--cytology
Survival Rate
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha--therapeutic use